Research Institute for Tropical Medicine

Similar documents
Laboratory Biosecurity: A Survey of the U.S. Bioscience Community

Episouth plus Project Mediterranean Regional Lab Network (MRLN)

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

A BSL-1 lab houses activities that require only standard microbial practices. These include:

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

Present State and Measures against Infectious Diseases in Tokyo

Biosafety Basics. Patrick Stockton, Director, Office of Biosafety Biosafety Community Liaison Committee June 26, 2017

Laboratory Services and Networks Your priorities?

Laboratory Survey Results. Preventing disease, promoting and protecting health

Risks of Emerging Infectious Diseases in ASEAN. Prasit Palittapongarnpim, M.D. Department of Microbiology, Faculty of Science, Mahidol University

Overview Existing, Emerging, and Re-Emerging Communicable Diseases

UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI

AAHL s Regional One-Health Activities

Advances in Pathogen Detection and Diagnostic Tools for Infectious Diseases. Maria Rosario Z. Capeding, MD, FPPS, FPIDSP

RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic

Introduction. Objectives. Risk Classification. Biologic Hazards

PANDEMIC INFLUENZA RESPONSE PLAN

Introduction. Infections acquired by travellers

Travel and transport risk assessment. Preparedness for potential outbreak of

Dr. Jim LeDuc Director Galveston National Laboratory University of Texas Medical Branch. 29 October 2015

Isolation Precautions in Clinics

Practical Biosecurity Check List

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Yale Environmental Health & Safety Update Form for Request to Use Infectious Agents Status of Protocol

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013

Secure Egg Supply. Maintaining a Secure Egg Supply During a Highly Pathogenic Avian Influenza Outbreak

Science. Systems Policy Process Programs People

Health Security in Southeast Asia

Network for Prevention and Control of Leptospirosis in Asia

Notes from the Sentinel Liaison

Annex H - Pandemic or Disease Outbreak

CHINESE INFORMATION SYSTEM FOR INFECTIOUS DISEASES CONTROL AND PREVENTION. Center for Public Health Surveillance and Information Services, China CDC

UNICEF s Response to the Ebola Crisis. Presenta(on to the Execu(ve Board, Informal Session, 11 September 2014

Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines

Orientation Program for Infection Control Professionals

Infectious Disease Surveillance System in Korea. Byungguk Yang Korea Centers for Disease Control and Prevention

Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report

Infectious Diseases Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health Assignment Description

IT and Information Acceptable Use Policy

Title: Supplementary guidelines on handling of

COMMUNICABLE DISEASES AND BLOODBORNE PATHOGENS IN THE WORKPLACE

Local Public Health Department. Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine

SECTION 11 IMMUNIZATION WORK PLANS

6/6/2012. General Information (3)

Association of Public Health Laboratories

Agents of Bioterrorism: Argument for and Against a List That Needs Cropping

Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report

An Overview Of The Communicable Disease Situation In Singapore, 2000

Infectious Diseases Weekly Report. 14 March 2013 / Number 10

Healthcare Professionals

Tokyo Medical Association s Measures against Infectious Diseases

Local Government Pandemic Influenza Planning. Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator

Events detected by national surveillance system (see Annex 1)

Monitoring results: goals, strategic objectives and indicators

Infectious Diseases Michigan Department of Health and Human Services, Bureau of Disease Control, Prevention and Epidemiology Lansing, Michigan

19-30 June 2004 UK PRESENTATION ON PREVENTION, INVESTIGATION AND CONTROL OF HUMAN INFECTIOUS DISEASE

Epidemiological News Bulletin

Science Applied to. Saving Lives. Uganda s Progress in. Implementing Lab. Biosafety / Biosecurity

Infectious Diseases-HAI, Infectious Diseases Arizona Department of Health Services, Public Health Services. Phoenix, Arizona. Assignment Description

Taiwan FETP -- Current Status & Perspectives

Communication and Integration Strategy

Proliferation Threats from Biotechnology: What is Dual-Use Research?

The Current Status of the Epidemiologic Transition

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES

4.3.9 Pandemic Disease

CONTACTS & ACKNOWLEDGEMENTS

HEALTHCARE WORKER INFLUENZA VACCINATION POLICY

EVALUATION OF HEALTH THREATS: How the EU system functions Zsuzsanna Jakab, Director of ECDC, Informal Meeting of Health Ministers

Overview of biosecurity systems in EU Member States. Milos Juras Food and Veterinary Office Unit F6 Animal and Welfare Grange, Dunsany (MH) - Ireland

Vaccine Innovation and Adult Immunization Landscape

Guidance Document Infectious Substances

Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do

Bioterrorism and the Pandemic Potential

Alberta Notifiable Disease Incidence

North York General Hospital Policy Manual

CDC s Global Disease Detection Program

USDA APHIS One Health Initiative

Weekly Influenza Activity: Statistics Summary

Staff Immunisation Policy

Weekly Influenza & Respiratory Activity: Statistics Summary

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

Adapting Biosecurity to Meet the Demands of Emerging Infectious Disease: Applications for Global Health Security

Diagnosis of infectious diseases and confirmation of diagnosis. Molecular epidemiology of emerging/re-emerging pathogens

B. Tasks and Procedures where employees, students or contractors can be exposed to bloodborne pathogens:

Disease Prevention, Detection & Response During Public Health Emergencies

What you need to know... Notifiable Diseases/Conditions. Alabama Department of Public Health (ADPH) Bureau of Communicable Disease - Epidemiology

Biosafety Level 2 Standard Practices and Containment Office of Research Safety Affairs

AREAS OF CONCENTRATION

Port Gamble S'Klallam Tribe POLICIES/PROCEDURES. Employee Immunity Assessment and Immunization Policy

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Burton's Microbiology for the Health Sciences

Transcription:

Research Institute for Tropical Medicine A model facility for safe and secure handling of high-risk pathogens REMIGIO M. OLVEDA, MD Director IV

What is RITM? History 1981: Japanese ODA through JICA established research laboratories and a 50-bed hospital for research and service 1985 : Animal laboratory 1989: Training center / residence hall 2002: National Tuberculosis Reference Laboratory Functions Main research arm of DOH for infectious and tropical diseases (1981) National Reference Laboratories for infectious disease including emerging pathogens (2000) Designated Referral Hospital for Emerging and Reemerging Infections (2004) Repository of isolates - from research, reference laboratory, surveillance activities

RITM Research Programs 1981 Research Projects Acute respiratory infections Diarrheal diseases Schistosomiasis 2008 Multidisciplinary Research Groups Acute respiratory infections Diarrheal disease Schistosomiasis Dengue Filovirus Hepatitis HIV/AIDS Leprosy Malaria Rabies TB Orphan infectious diseases

RITM National Reference Laboratories Department Order 393-E, November 2000 Dengue Influenza Measles and other viral exanthems Enteroviruses Bacterial enteric diseases Antimicrobial resistance Mycology Tuberculosis and other Mycobacteria Malaria and other parasites Emerging Diseases NRL for confirmatory testing of blood donors and blood units Rabies (2009) Japanese encephalitis (2010)

Laboratory based surveillance Influenza (WHO recognized National Influenza Center ) Measles and other exanthems ( in support of Philippine Measles Elimination Campaign/PMEC) Enteroviruses from Acute flaccid paralysis/afp surveillance (WHO recognized National Polio Laboratory) Dengue JE and other causes of meningitis and meningoencephalitis

NEC OUTBREAK INVESTIGATIONS

Diarrheal disease outbreak investigations 2007 outbreaks of Shigella flexneri resistant to Ampicillin, Cotrimoxazole, Chloramphenicol January Bohol April Cotabato July Cavite 2008 outbreaks of Salmonella typhi January Nueva Viscaya March Laguna and Samar April Misamis Oriental

Diarrheal disease outbreak investigations

* Pathogens are of interest to terrorists because of the fear, panic, anxiety and terror they may cause, aside from the great economic losses. Emerging Infections*: RITM Response 2009 2008 H1N1/ Leptospirosis Ebola in pigs and humans 2005 2004 2003 Laboratory Preparedness to Avian Influenza Virus Meningococcemia outbreak in CAR SARS Outbreak 2002 2001 1998 West Nile Virus Pseudo outbreak (RITM as Referral Laboratory) Bioterrorism threat using Bacillus anthracis as biological weapon Serological Surveillance ABLV 1989 Serological Surveillance Ebola Reston Virus Outbreak of Ebola Reston

Time Index of RITM Response SARS Outbreak 2003 2003 RITM served as Reference Laboratory for SARS-specific diagnostic tests, special tests to rule out other causes of atypical pneumonia and for specimen/tissue banking for future tests. MWM 1 2 3 4 5 6 AC MC AC MC 600 200 100 110 bp (ß-globin) 128 bp (SARS1s/SARS1as) RITM was able to confirm SARS infection in eight patients by molecular detection and/or ELISA. BSL2+ Laboratory The National Reference Laboratory for Emerging and Reemerging Viral Zoonoses

Meningococcemia in CAR Nov 2004 Dec 2005 2004 RITM role Culture (+) for N. meningitidis Serogroup A: 145 (34.6%) of 419 cases with clinical samples Role of WHO Collaborating Center Further characterization by Typing, Subtyping, PFGE & MLST: Type 4, serotype P1.9 sequence type 7 & ST-5 complex Garnotel et al ; WHO Collaborating Center for Meningococcal Disease Marseilles, France

2009 Source: NIC-RITM Website weekly update (http://www.influenzasurveillancephilippines.org/content/weekly-updates)

BIOSECURITY RISK ASSESSMENT

Strategy It is impossible to eliminate all risk; risk can only be managed. Risk-based, graded protection strategy at the RITM facility Undesired events judged to present the highest risk to a facility receive the highest level of protection.

RITM Biosecurity Risk Prioritization Methodology Joint Sandia National Laboratory and RITM teams January 2007 Evaluating the assets Evaluating the potential adversaries Creating scenarios Evaluating the vulnerabilities Evaluating the risk (threat potential and consequences) of those scenarios occurring.

BIOSECURITY RISK FLOWCHART BIOSECURITY RISK Evaluating the risk THREAT POTENTIAL CONSEQUENCES Population, economic, psychological and operational impact Agent task complexity= acquisition, development, dissemination Evaluating the assets Site vulnerability= physical, personnel, information, transport security, MCA, program management Adversary attributes= motive, means, opportunities Evaluating the potential adversaries Evaluating the vulnerabilities

Biological assets at RITM Species Biosafety Risk Group Why Screened Biosecurity Risk Group Dengue 2 or 3 Mosquito-borne, difficult to disseminate Low Risk E. coli O157 3 Moderate Risk Ebola Reston 4 Moderate Risk HIV 2 or 3 Difficult to disseminate Low Risk Japanese encephalitis 3 Mosquito-borne, difficult to disseminate Moderate Risk M. tuberculosis 3 Moderate Risk S. aureus 2 Very common worldwide, opportunistic pathogen Moderate Risk N. meningitidis 2 Common worldwide, most infections are inapparent Low Risk P. falciparum 2 Common, difficult to disseminate, Mosquito-borne Low Risk Polio 2 Low Risk

Species Biological assets at RITM Biosafety Risk Group Rabies 2 or 3 Rhinovirus spp 2 Why Screened Common in many areas of the world; difficult to disseminate (aerosol transmission documented only under unique circumstances) Ubiquitous in environment; opportunistic pathogen, mild illness Biosecurity Risk Group Low Risk Low Risk Parainfluenza Ubiquitous in environment; mild illness Low Risk RSV 2 Ubiquitous in environment; opportunistic pathogen, mild illness Low Risk S. typhi 2 or 3 Moderate Risk SARS 3 Moderate Risk S. dysenteriae 2 Moderate Risk Snake venom toxins Stored as crystals; difficult to disseminate Low Risk V. cholerae 2 Moderate Risk Influenza A 2 Common worldwide, most infections are mild in healthy adults Low Risk

Assets and potential adversaries Pathogen Perpetuator Level of security risk SARS virus Insider High terrorist group colluding with an insider terrorist group or single terrorist Moderate to high Moderate MDR-TB Insider terrorist Moderate to high Ebola Reston virus terrorist group colluding with an insider, terrorist group or single terrorist Insider, terrorist group colluding with an insider or terrorist group single terrorist M. tuberculosis Insider or terrorist group colluding with an insider terrorist group or single terrorist Moderate Moderate Low to moderate Moderate Low to moderate

Site vulnerability - Physical security Site perimeter secured. Locking doors to laboratories at night Access control procedures are very weak and for the most part ineffective. Guard force provides some level of security, but even this is ineffective given the openness of the campus. The general public can be found virtually anywhere on the campus during normal working hours and their presence is not questioned by the guards. Some CCTV cameras are installed in certain locations; however, the guard responsible for monitoring the cameras has other duties and is usually preoccupied by other attentions.

Site vulnerability Program management No formal biosecurity plan or official who oversees biosecurity. No security training to staff when hired or on a regular basis. Some awareness of security practices are explained and reinforced within the specific laboratory but not at an institutional level. No formal SOPs or guidance for institutional security and in many areas the security practices seem to be limited due to funding constraints.

Site vulnerability Personnel security RITM permanent staff Staff are hired based on applications that include biodata, transcripts, and certifications or licenses where applicable. NBI clearance is required. Orientation program for new hires which includes policies and procedures on administration and overall RITM policies. Laboratory supervisor is responsible for all hands on training within the lab. Upon termination of employment, all employees go through a clearance process. Badges are required based on policies, but in practice are rarely worn. A list of authorized personnel is given to the guards for collection of keys. The guard force manages all the keys within RITM and logs in and out who has each key. Overtime protocol requires approval and documentation, but this practice is not strictly enforced. The guards do not challenge laboratory staff if they are in the lab after hours they assume it is allowed, and do not ask for verification of identity or overtime approval. Permanent employees sign in and out of the building.

Site vulnerability Personnel security Contractual staff Staff are hired based on applications that include biodata, transcripts, and certifications or licenses where applicable. No NBI clearance is required. Not provided with badges, but do have ID cards. They do keep daily time records which are signed by the project lead. The foundation provides a general orientation but the project lead is required to provide and safety training and laboratory instruction. The exit process for foundation staff includes a clearance process and the final pay check is withheld until this clearance process has been completed.

Site vulnerability Material control and accountability RITM has no system for accurate material control and accountability a high-risk pathogen could be stolen. Each laboratory maintains its own schedule for conducting inventories, with few having recent and complete inventories.

Site vulnerability transportation security Receive requests for isolates from research laboratories and even students Current procedures for refilling liquid nitrogen dewars entail transporting the containers to the outside business to be refilled. IATA guidelines when shipping samples internationally. No established protocols regarding shipment of samples within the Philippines, though there is a process. Samples are delivered by courier directly to the laboratory or are received by the guards, who take them to the appropriate laboratory themselves. This occasionally results in the gate or guard post being left unmanned. Samples are left unattended in the laboratory anteroom when no laboratory personnel are available to receive them.

Site vulnerability information security There is little information of high value from a biosecurity standpoint on the RITM network. However, the network is generally wide open and any form of sensitive data would not be adequately protected on this network. RITM does have some information protection guidance. This is focused on patient confidentiality and media interactions in response to outbreaks. After the SARS outbreak, a chain of command for media interactions was formed, and people known to be in violation of breaking this communications chain have been informally reprimanded. Laboratory results regarding HIV status are treated confidentially.

Threat Potential RITM Biosecurity Risk 4 Burkolderia pseudomallei Colluding Terrorist Group 3.5 Burkolderia pseudomallei Insider Terrorist Burkolderia pseudomallei Single Terrorist Burkolderia pseudomallei Terrorist Group 3 2.5 2 Ebola Reston Virus Colluding Terrorist Group Ebola Reston Virus Insider Terrorist Ebola Reston Virus Single Terrorist Ebola Reston Virus Terrorist Group MDR-TB Colluding Terrorist Group MDR-TB Insider Terrorist MDR-TB Single Terrorist MDR-TB Terrorist Group 1.5 1 0.5 Mycobacterium tubercuosis Colluding Terrorist Group Mycobacterium tubercuosis Insider Terrorist Mycobacterium tubercuosis Single Terrorist Mycobacterium tubercuosis Terrorist Group SARS Colluding Terrorist Group SARS Insider Terrorist SARS Single Terrorist SARS Terrorist Group 0 0 0.5 1 1.5 2 2.5 3 3.5 4 Consequences

Threat Potential Threat Potential Target of mitigation decrease the risk 4 RITM Biosecurity Risk: Pre-Mitigation 4 RITM Biosecurity Risk: Post-Mitigation 3.5 3.5 3 3 2.5 2.5 2 2 1.5 1.5 1 1 0.5 0.5 0 0 0.5 1 1.5 2 Consequences 2.5 3 3.5 4 0 0 0.5 1 1.5 2 Consequences 2.5 3 3.5 4

RISK MITIGATION RECOMMENDATIONS AND ACTIONS

Physical security Recommendation Secure the pathogens in the warehouse by restricting access to this building and by installing simple locks on freezers containing high-risk pathogens. RITM action with Sandia support A portion of the warehouse has been enclosed with bars to house Risk Group 2 and 3 pathogens. Warehouse containing different Pathogens Electronic Security Access System Enclosed portion of the Warehouse (Jailhouse)

Recommendation Installation of specific biosecurity equipment and technologies Physical security RITM action with Sandia support A security system with automated access control, intrusion detection and 16 CCTVs for alarm assessment, all integrated with a Central Alarm Station, has been installed. Currently, used for investigations as no permanent personnel can be assigned to the station. Central Monitoring Station Motion sensor at NTRL Culture Lab

Recommendation: Access control to other laboratories should also be improved. WE DEFINED OUR FACILITY BY ASSETS THAT WE KEEP. PROPERTY PROTECTION AREAS - LOW RISK ASSETS Grounds Public access offices LIMITED ACCESS AREAS Laboratory Research Wing Vaccine Production Areas RESTRICTED AREAS - Moderate risk assets Virology Annex Microbiology Laboratory ARS Laboratory Veterinary Research Department (Experimental Animal Facility) BCG Vaccine Production Area Freezer Room Highly Restricted Areas - High risk assets TB Culture Laboratory, NTRL Building Rabies and Special Pathogens Laboratories TB Unit, Microbiology Laboratory Biosafety Level 3 Laboratory Select area with freezers with high risk pathogens, Isolate and Sample Bank Physical security

PHYSICAL SECURITY SIMPLE MEASURES LIMITED ACCESS AREAS RESTRICTED AREAS HIGHLY RESTRICTED AREAS *PIN for access and alarm system (sensors inside) Laboratory Research Wing Vaccine Production Areas Virology Annex Microbiology Laboratory ARS Laboratory Veterinary Research Department (Experimental Animal Facility) BCG Vaccine Production Area Freezer Room * TB Culture Laboratory, NTRL Building *Rabies and Special Pathogens Laboratories *TB Unit, Microbiology Laboratory Biosafety Level 3 (2+) Laboratory Select area with freezers with high risk pathogens, Isolate and Sample Bank, Warehouse

Physical security Upgrading of facilities - isolate the laboratory research wing - access to main door to laboratory one entry and one exit

PROGRAM MANAGEMENT Recommendations Long-term biosecurity plan that documents all necessary Standard Operating Procedures and incident response plans, Biosecurity training for RITM staff that is directly relevant to their specific job functions. Achieved so far at RITM SOP on Security in place for protection of physical facility, personnel, patients Some biosecurity orientation/training for laboratory staff. Coordination between the policy-maker (Biosafety and Biosecurity Officer) and the program implementation officer (Administrative Officer) is on-going.

Personnel Security Recommendations Standardized screening process should be in place for all personnel working within the laboratories. Practices regarding badging should be standardized. Achieved so far A standardized screening process is in place for newly hired permanent and contractual personnel working within the laboratories. Identified laboratory personnel with access and PIN to TB Culture, Special Pathogens and Rabies, BSL3 laboratories Permission for OT after 5pm is secured from the Admin Officer.

Personnel Security What still needs to be done? SOPs for research contract personnel Principal investigators and researchers to provide list of contractuals, duties and responsibilities to AO/ Personnel Department for orientation and monitoring. Personnel IDs/badges and biometrics for logging in and out and time keeping will be upgraded with access and information on duration of access to the facility

Personnel security Practices regarding badging will be standardized. 1. Persons with authorized access to the laboratories should wear their badges so that they are clearly visible, except in situations where this could compromise safety. 2. Badges will be provided for contractors as well as visitors to the lab areas. 3. Ideally, badges will reflect the level of access authorized for the wearer. 4. Persons not wearing proper badges will not be permitted entry into restricted access areas.

Material Control & Accountability Recommendation Establish a complete, current inventory of pathogens Achieved so far: 1. Each laboratory maintains its own schedule for conducting inventories. 2. Bar coding of new samples and isolates is being done. 3. Each laboratory has identified authorized individuals who can access the samples and the data. 4. SOPs for conducting routine inventory of stocks and for determining when to dispose of isolates or samples Back up database

Material Control & Accountability Still to be done RITM will establish a complete, centralized computer based inventory of pathogens. Establish SOPs for sharing and tracking isolates within the facility. Proposed National Survey for Inventory of isolates and samples

Transportation Security Recommendations RITM needs its own supply of liquid nitrogen, from which the staff can refill individual dewars themselves, particularly those that contain high-risk organisms. Achieved so far Standard SOPs for shipping security and handling in transport in place Setting up large filling dewars or tanks to supply liquid nitrogen to individual dewars, particularly those that contain high-risk organisms will be required as part of a contract for services regarding provision of LN.

Risk mitigation recommendations Information Security RITM program management needs to create standard information policies which include sensitive personal information and biosecurityrelated information. RITM network users should be required to maintain a minimum level of security on computers and data

Safe and secure laboratories 1. Ensure the containment of hazardous infectious substances in laboratories 2. Maintain citizens confidence in the activities of the bioscience research community 3. Increase transparency to investors in the biomedical and biotechnology industries 4. Protect valuable research and commercial assets 5. Reduce the risks of crime and bioterrorism

THANK YOU!